Influenza Congress USA 2011 is North America’s most in depth, commercially focused flu conference
Victoria Landolfi
Sanofi Pasteur
Influenza Congress USA brings together key stakeholders from pharma, biotech, government, academia and finance to discuss candidate commercialization, revenue generation, market supply, policy & planning, R&D and partnerships. It is a three-day executive summit with exhibition.
Register to attend Influenza Congress USA »
Come to Influenza Congress USA and learn:
- How to ensure rapid production and safety of 'flu seasonal pandemic vaccines
- How to integrate development and licensure of new 'flu vaccines
- How to improve titers, breadth, and dose-recovery using adjuvants, and understand the current status of adjuvant regulation in the US
- How to boost product pipelines by identifying novel technologies and biotech companies worthy of investment
Influenza Congress USA is where the immediate future of the seasonal and pandemic 'flu vaccine will be determined. Confirm your place today!
Register for Influenza Congress USA 2011 »
Download conference brochure »
|
An unrivalled speaker line-up, including:
- FDA
- EMA
- GSK
- Novartis Vaccines & Diagnostics
- CSL Biotherapies
- Sinovac
- Sanofi Pasteur
- TechnoVax
- Dynavax
- Isconova
- Pharmajet
- Vaxart
- Wittycell
- Bionor Pharma
- GE Healthcare Life Sciences
- Centers for Disease Control and Prevention
- US Department of Health and Human Services
Download the brochure »
Register now for influenza congress »
|
The Influenza Congress USA focus:
- Success via public-private partnership
- Adjuvant regulation
- Flu vaccine adjuvant technology
- Innovative flu vaccine technologies
- Antivirals: Pending the availability of vaccines
- Developing a universal flu vaccine
- Clinical trials in healthy individuals
- Vaccine delivery options
- Manufacturing and distribution solutions
- Global market expansion
If it's important for your organization to stay on top of these critical areas, then you must attend.
Register now »
Download the brochure »
Enquire about sponsorship »
|
 |
 |
 |
Who should attend:
- Equipment & technology providers
- Pharmaceuticals
- Biotechs
- CROs
- Academics & research organizations
- Government regulators
- CMOs
- Grant funding agencies
- VCs
Register for influenza conference »
Download conference brochure » |
World class healthcare solutions providers attend:
- To identify novel flu vaccine and delivery technologies
- Acquire government and VC funding
- Form strategic partnerships
- Gain understanding of the FDA's update on adjuvants
- Raise your profile and gain credibility in the flu vaccine industry
Download the brochure »
Email us now for more details »
|
 |